Latest filing published 04 Jun 2025 for Novocure Ltd, €15k.
Filing timeline
BuySaleInsider track record
Martin J. Madden: trading record in brief
Martin J. Madden (board member) discloses dealings in Novocure Ltd to SEC (Form 4). We count 9 filings; the first trade dates from 21 May 2019 and the latest from 3 June 2025.
No open-market purchase appears, only 2 sales worth €19k. Besides market trades, the filings include 6 share grants and 1 option exercise. 2025 to date brings no purchases and 1 sale.
The latest filing, published on 4 June 2025, reports an open-market sale of €15k in Novocure Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Martin J. Madden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 999 shares@ US$17.192877.4% of flowOrdinary SharesSEC:0001562180-25-004438:0
- 4,053 shares0Ordinary SharesSEC:0001562180-24-004774:0
- 34 shares@ US$153.1322.6% of flowOrdinary SharesSEC:0001645113-21-000101:0
- 814 shares0Restricted Stock UnitsSEC:0001645113-21-000078:0
- 111 shares0Restricted Share UnitsSEC:0001645113-21-000034:0
- 307 shares0Restricted Stock UnitsSEC:0001645113-20-000117:0
- 2,541 shares0Restricted Stock UnitsSEC:0001645113-20-000088:0
- 3,359 shares0Restricted Stock UnitsSEC:0001209191-19-032687:0
- 8,906 shares@ US$48.8795.2% of flowOrdinary SharesSEC:0001209191-19-032046:0
9 of 9 declarations
